Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc > .15 wall down and soon to be .155 as well

<< Previous

Bullboard Posts

Next >>

Comment by GoldenHawkon Jun 29, 2018 2:10pm

52 Views

Post# 28252847

RE:RE:.15 wall down and soon to be .155 as well

And it will. We know the results are coming and they are all positive as per the meeting. How positive is going to reflect on the share price but no matter what it’s definitely going up. These prices are laughable as to what’s coming. Like I said, I’m going into the long weekend loaded for next week!

HouseSpeaker007 wrote:

GoldenHawk wrote: Will close between .18 and .20 today.

If .155 comes down I do not doubt it, it can very well trade above .20 before news comes out.